Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142275 |
| CAS No | NA |
| Mol.F. | C23H24I2N2O5 |
| Mol.Wt. | 662.26 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142276 |
| CAS No | NA |
| Mol.F. | C23H22I2N2O5 |
| Mol.Wt. | 660.25 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142277 |
| CAS No | NA |
| Mol.F. | C25H30N2O4 |
| Mol.Wt. | 422.53 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142278 |
| CAS No | NA |
| Mol.F. | C15H22N4O5S |
| Mol.Wt. | 370 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142279 |
| CAS No | NA |
| Mol.F. | C5H11N3O |
| Mol.Wt. | 129.16 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142280 |
| CAS No | NA |
| Mol.F. | C14H20N4O5S |
| Mol.Wt. | 356.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142281 |
| CAS No | NA |
| Mol.F. | C13H17IN4O3 |
| Mol.Wt. | 404.21 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142282 |
| CAS No | NA |
| Mol.F. | C16H24N4O5S |
| Mol.Wt. | 384.45 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142283 |
| CAS No | NA |
| Mol.F. | C14H20IN3O2 |
| Mol.Wt. | 389.24 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142284 |
| CAS No | NA |
| Mol.F. | C16H23N3O5S |
| Mol.Wt. | 369.44 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142285 |
| CAS No | NA |
| Mol.F. | C10H13N3O |
| Mol.Wt. | 191.23 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142286 |
| CAS No | NA |
| Mol.F. | C17H19N3O |
| Mol.Wt. | 281.36 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142287 |
| CAS No | NA |
| Mol.F. | C14H22N4O3 |
| Mol.Wt. | 294.36 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142288 |
| CAS No | NA |
| Mol.F. | C15H10ClN3O2 |
| Mol.Wt. | 299.71 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142289 |
| CAS No | NA |
| Mol.F. | C11H15N3O3 |
| Mol.Wt. | 237.26 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142290 |
| CAS No | NA |
| Mol.F. | C18H17ClN4O2 |
| Mol.Wt. | 356.81 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |